Goldfinch Bio

Updated: September 28, 2025

Anthony Johnson, CEO

Country: USA | Funding: $210M (+)

Website: https://www.goldfinchbio.com#no

Goldfinch is singularly focused on discovering and developing precision therapies for patients with kidney disease. Temporarily closed

Competitors